Massarico Serafim Ricardo Augusto, Gonçalves José Eduardo, de Souza Felipe Pereira, de Melo Loureiro Ana Paula, Storpirtis Silvia, Krogh Renata, Andricopulo Adriano Defini, Dias Luiz Carlos, Ferreira Elizabeth Igne
LAPEN - Laboratório de Planejamento e Síntese de Quimioterápicos Potencialmente Ativos contra Doenças Negligenciadas, Universidade de São Paulo (USP), Faculdade de Ciências Farmacêuticas, Departamento de Farmácia, Av. Prof. Lineu Prestes, 580, 05508-900 São Paulo, SP, Brazil.
LPFCC - Laboratório de Permeabilidade de Fármacos em Culturas Celulares, Universidade de São Paulo (USP), Faculdade de Ciências Farmacêuticas, Departamento de Farmácia, São Paulo, SP, Brazil.
Eur J Med Chem. 2014 Jul 23;82:418-25. doi: 10.1016/j.ejmech.2014.05.077. Epub 2014 Jun 3.
Hybrid bioisoster derivatives from N-acylhydrazones and furoxan groups were designed with the objective of obtaining at least a dual mechanism of action: cruzain inhibition and nitric oxide (NO) releasing activity. Fifteen designed compounds were synthesized varying the substitution in N-acylhydrazone and in furoxan group as well. They had its anti-Trypanosoma cruzi activity in amastigotes forms, NO releasing potential and inhibitory cruzain activity evaluated. The two most active compounds (6, 14) both in the parasite amastigotes and in the enzyme contain the nitro group in para position of the aromatic ring. The permeability screening in Caco-2 cell and cytotoxicity assay in human cells were performed for those most active compounds and both showed to be less cytotoxic than the reference drug, benznidazole. Compound 6 was the most promising, since besides activity it showed good permeability and selectivity index, higher than the reference drug. Thereby the compound 6 was considered as a possible candidate for additional studies.
设计了来自酰腙和呋咱基团的杂化生物电子等排体衍生物,目的是至少获得双重作用机制:抑制克氏锥虫蛋白酶(cruzain)和释放一氧化氮(NO)的活性。合成了15种设计化合物,同时改变了酰腙和呋咱基团中的取代基。对它们在无鞭毛体形式下的抗克鲁斯锥虫活性、释放NO的潜力和抑制克氏锥虫蛋白酶活性进行了评估。在寄生虫无鞭毛体和酶中活性最高的两种化合物(6、14)在芳环的对位均含有硝基。对这些活性最高的化合物进行了Caco-2细胞通透性筛选和人细胞毒性测定,结果表明它们的细胞毒性均低于参比药物苯硝唑。化合物6最有前景,因为除了活性外,它还表现出良好的通透性和选择性指数,高于参比药物。因此,化合物6被认为是进一步研究的可能候选物。